Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
來自BioNTech分析師評級的關鍵見解：你需要知道的
Across the recent three months, 11 analysts have shared their insights on BioNTech (NASDAQ:BNTX), expressing a variety of opinions spanning from bullish to bearish.
在最近三個月中，11位分析師分享了他們對BioNTech（納斯達克股票代碼：BNTX）的見解，表達了從看漲到看跌的各種觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.55, a high estimate of $171.00, and a low estimate of $90.00. This current average has increased by 1.79% from the previous average price target of $110.57.
分析師通過對12個月目標股價的評估提供了更深入的見解，顯示平均目標價爲112.55美元，最高估計爲171.00美元，低估值爲90.00美元。目前的平均價格較之前的平均目標價110.57美元上漲了1.79％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
In examining recent...
在研究...
登入免費觀看全文
登入/註冊